I agree We use cookies on this website to help us provide the best user experience. By browsing this site you agree to their use - more information is available here.

Barnett Waddingham
0333 11 11 222
Our specialist bulk annuity team has extensive experience of advising both trustees and companies on all aspects of buy-outs and buy-ins, encompassing both traditional and medically underwritten bulk annuity processes.

Our team has strong ongoing relationships with all of the bulk annuity providers in the market, enabling us to develop bespoke deal solutions and ensuring our clients are aware of any offerings which can help them transact more efficiently and cost effectively.

We are also supplemented by dedicated expertise in the key related areas of investment, longevity and insurer financial strength assessments.

Working in partnership with you, we can advise on all aspects of the de-risking process including:

  • preparation and feasibility ensuring your scheme is in position to achieve the maximum level of insurer engagement
  • process support and project management thorough planning to deliver the critical steps within the desired timescales 
  • price negotiation and deal structuring using our close insurer relationships and market knowledge to secure the best possible terms
  • due diligence of insurers helping you understand the regulatory environment, insurer risk and financial strength

Our combination of trustee and company experience allows us to understand the perspective of both parties in a bulk annuity transaction, helping to facilitate a smoother process whilst achieving the underlying aims for our client and the pension scheme overall.

We recognise that the nature of bulk annuity deals is similar to other corporate/scheme transactions, where there is a need to be flexible, to respond quickly and to provide the appropriate level of support.


Recent client engagements:
  • We have advised on a wide range of transactions, including processes in excess of £300 million through to transactions of under £5 million. This includes schemes relating to a number of large firms and multinationals based in the UK and overseas, as well as small to medium sized companies.
  • We have also advised several of the insurers in the bulk annuity market.
Do you need to carry out due diligence on your chosen insurer?

Related knowledge and resources

Blogs

  • Picture for Interest rates to rise but no return to normal anytime soon
    Interest rates to rise but no return to normal anytime soon

    Speakers from BlackRock, Columbia Threadneedle and Insight Investments all predict little prospect of a normalisation in interest rates over the next year at our annual conference - Matt Tickle examines the forecast in more detail in his latest blog.

  • Picture for Don’t be paralysed by political risk
    Don’t be paralysed by political risk

    Marcus Whitehead looks back at Rupert Harrison's Investment Conference talk which highlighted how investors over-reacted to political risk in 2016, why they shouldn't make the same mistake in 2017 and learn to tolerate a certain amount of volatility.

  • Picture for PPF reveals further fall in contingent funding arrangements
    PPF reveals further fall in contingent funding arrangements

    The PPF’s latest Purple Book reveals a fall in PPF-compliant contingent assets, driven by the PPF’s more robust approach to certification. Alternative approaches to reducing risk include security over assets and cash contributions.

  • Buy-outs and buy-ins – Winter 2016

    Significant bulk annuity and reinsurance transactions in the second half of the year see 2016 become another substantial year for the bulk annuity providers.

  • How to tackle your year-end pension problem

    In October, Carclo plc announced the rise in its accounting pension deficit meant that it was no longer able to pay its interim dividend. With this is mind, we discuss the impact of pension deficits on corporate balance sheets come the calendar year end.

  • Buy-outs and buy-ins - Autumn 2016

    Some significant recent transactions suggest that it could be a strong second half to 2016, following a quieter than usual start to the year. The period also saw one of the long-established bulk annuity insurers announcing its withdrawal from the market.

  • Picture for French companies with UK defined benefit schemes
    French companies with UK defined benefit schemes

    This survey looks at French companies, almost all of which are constituents of the CAC40 index, which have UK subsidiary companies with DB pension schemes. The survey covers 14 French companies with around £22.2bn of UK pension liabilities between them.

  • Picture for Dutch companies with UK defined benefit schemes
    Dutch companies with UK defined benefit schemes

    This survey relates to constituent companies of the Dutch AEX share index that have UK subsidiary companies with defined benefit (DB) pension schemes. The survey covers seven Dutch companies with around £9.3 billion of UK pension liabilities between them.

  • Picture for German companies with UK defined benefit schemes
    German companies with UK defined benefit schemes

    This survey examines German companies, the majority of which are constituents of the DAX index, which have UK subsidiary companies with DB pension schemes. The survey covers 21 German companies with around £26.4bn of UK pension liabilities between them.

  • De-risking without significant increases deficit recovery contributions

    As part of their most recent actuarial valuation, Tate & Lyle were seeking to continue to de-risk their £1 billion legacy DB pension scheme, but without a significant increase in deficit recovery contributions.

  • 'Top-Slicing' Medically Underwritten Buy-in

    We jointly advised trustees and company on a medically underwritten pensioner buy-in achieving very significant savings of >10% relative to traditional approach – successfully securing around £25m of the pensioner liability at no additional funding cost.

  • Innovative buy-out

    We carried out an innovative buy-out for part of the Lloyd’s Superannuation Fund (LSF), a £500m multi-employer defined benefit scheme associated with the Lloyd’s of London insurance market.

Barnett Waddingham Finance Directors Guide to Pensions
Finance Directors' Guide to Pensions

As a Finance Director, it is difficult to ensure you remain up to date with pensions developments that will impact on decisions you make.

Find out more

Register for your choice of email alerts

Stay ahead with our latest comment, expert insight and event details.